Sheba Medical Center
| Israel | Turki | Austria | |
| Transplantasi sumsum tulang autologus | dari $58,000 | dari $32,500 | dari $50,000 |
| Transplantasi sumsum tulang alogenik dari donor tidak sedarah | dari $150,000 | dari $66,000 | dari $180,000 |
| Transplantasi sumsum tulang allogenik dari donor terkait | dari $142,000 | dari $57,500 | dari $150,000 |
| Transplantasi sumsum tulang | dari $135,000 | dari $27,500 | dari $140,000 |
| Kemoterapi untuk kanker payudara | dari $22,500 | dari $1,200 | dari $15,000 |
Bookimed tidak menambah biaya tambahan dalam harga perawatan Limfoma Burkitt. Tarif berasal dari daftar harga resmi klinik. Anda membayar langsung di klinik saat tiba di negara tujuan untuk perawatan Anda.
Bookimed berkomitmen pada keselamatan Anda. Kami hanya bekerja dengan institusi medis yang menjaga standar internasional tinggi dalam perawatan Limfoma Burkitt dan memiliki izin yang dibutuhkan untuk melayani pasien internasional di seluruh dunia.
Bookimed menawarkan bantuan ahli gratis. Koordinator medis pribadi mendukung Anda sebelum, selama, dan setelah perawatan, menyelesaikan semua masalah Anda. Anda tidak pernah sendirian dalam perjalanan perawatan Limfoma Burkitt Anda.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.